APDN appoints Hurry as ED IR and corporate communications

August 01, 2020 - United States Of America

Applied DNA Sciences, a leader in polymerase chain reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions, has appointed Sanjay Hurry to executive director of investor relations and corporate communications. Hurry will oversee company's outreach with the investor company and will report to Dr James Hayward, president and CEO.
 
“We are thrilled to have Hurry on board as we work to increase and enhance our engagement with the investor community,” Dr Hayward said in a press release. “His demonstrated success in building strategic communications programmes that support business growth and deep understanding of Applied DNA’s business will be key to helping us broaden Wall Street's awareness of our proprietary PCR-based linear DNA manufacturing platform and its multiple applications across industrial and therapeutic industries, the latter our emerging diagnostics and vaccine development programmes.”
 
Hurry brings over 20 years of investor relations and corporate communications experience for public companies and with investor relations agencies across a spectrum of diverse industries. For the past five years he served as vice president at LHA investor relations, Applied DNA’s agency of record. He holds a BA from New York University.